Explore All Access
Check if your research matches the topics covered in CNS Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
CNS Drugs : Impact Factor & More
eISSN: 1179-1934pISSN: 1172-7047
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
CNS Drugs Key Metrics
CiteScore 
9.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology (clinical)
SNIP
1.87
Topics Covered on CNS Drugs
CNS Drugs Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS Drugs
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
- 3 Apr 2025
- CNS Drugs
Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.
- 1 Apr 2025
- CNS drugs
Clozapine-Related Tachycardia: An Analysis of Incidence.
- 23 Mar 2025
- CNS drugs
Correction: Antiseizure Medications and Sudden Unexpected Death in Epilepsy: An Updated Review.
- 22 Mar 2025
- CNS drugs
Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial.
- 20 Mar 2025
- CNS drugs
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON Trial.
- 20 Mar 2025
- CNS drugs
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
- 3 Apr 2025
- CNS Drugs
Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.
- 1 Apr 2025
- CNS drugs
Clozapine-Related Tachycardia: An Analysis of Incidence.
- 23 Mar 2025
- CNS drugs
Correction: Antiseizure Medications and Sudden Unexpected Death in Epilepsy: An Updated Review.
- 22 Mar 2025
- CNS drugs
Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial.
- 20 Mar 2025
- CNS drugs
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON Trial.
- 20 Mar 2025
- CNS drugs
Compare Similar Journals with CNS Drugs
Select Journals to Compare with CNS Drugs
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Frontiers in Neurology
Publisher: FRONTIERS MEDIA SA
Scientific Reports
Publisher: NATURE PORTFOLIO
Neurology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Journal of Clinical Medicine
Publisher: MDPI
Medicine
Publisher: Elsevier
Frontiers in Psychiatry
Publisher: FRONTIERS MEDIA SA
0 Journals Selected to compare with
CNS Drugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
Your document is 100% secure & confidential 
